|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Interest earning cash at other financial institutions | ||||||||||||||||||||
| Securities available-for-sale, at fair value | ||||||||||||||||||||
| FHLB Stock | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans, net of allowance for loan losses of $10,715 as of September 30, 2021; $14,808 as of December 31, 2020 | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Loan servicing rights | ||||||||||||||||||||
| Other real estate owned, net | ||||||||||||||||||||
| Cash surrender value of bank owned life insurance | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Core deposit intangible, net of accumulated amortization of $1,798 as of September 30, 2021; $1,747 as of December 31, 2020 | ||||||||||||||||||||
| Accrued interest receivable and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Advances from FHLB | ||||||||||||||||||||
| Subordinated debentures | ||||||||||||||||||||
| Deferred tax liability, net | ||||||||||||||||||||
| Accrued interest payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Preferred stock- $1,000 stated value; 15,000 shares authorized; 8,000 shares issued | ||||||||||||||||||||
| Common stock - $0.01 par value; 50,000,000 authorized; 7,277,097 shares issued and 6,053,369 shares outstanding as of September 30, 2021; 7,212,727 shares issued and 6,197,965 shares outstanding as of December 31, 2020 | ||||||||||||||||||||
| Surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock, at cost; 1,223,728 shares at September 30, 2021; 1,014,762 shares at December 31, 2020 | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity |
Loading...
